The stock of Medidata (MDSO) continues to break new ground to the upside on the back of some strong fundamentals. How will this stock fare as we head into the home stretch of the second quarter of 2019?
The fundamentals for Medidata Solutions are strong, given the diversified nature of its revenue base. Its cloud-based platform which connects patient with doctors and other healthcare professionals continues to attract attention from the paying market as well as from other companies interested in leveraging on this product to build strategic alliances. One such alliance between Medidata and Cognizant (NASDAQ:CTSH) has already been established. This alliance will bring together expertise from Cognizant in digital services and solutions from the Medidata platform to create tools which will help ease the growing complexities in projects such as clinical trials.